Two Sigma Investments’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
CF
MBAM
Two Sigma Investments's HCAT Position: Q3 2026 in Review
Two Sigma Investments increased its Health Catalyst (HCAT) stake by 95% in Q3 2026, buying an estimated $24.9K and bringing the position to 26,738 shares worth $46.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4758.
Two Sigma Investments first reported a position in HCAT in Q1 2020 and has held it in 19 quarters since. The position peaked at $8.71M in Q1 2021. 109 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.
- Two Sigma Investments held 26,738 shares of Health Catalyst worth $46.3K as of Q3 2026.
- Two Sigma Investments bought 13,025 Health Catalyst shares in Q3 2026, an estimated $24.9K.
- Health Catalyst made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #4758 holding.
- Two Sigma Investments first reported a position in Health Catalyst in Q1 2020 and has held it in 19 quarters since.
- Two Sigma Investments's Health Catalyst position peaked at $8.71M in Q1 2021.
- 109 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.